By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

bluebird bio inc is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird's revenue is derived from collaboration arrangements, research fees, license fees, and grant revenue. The company works with industry peers, strategic partners, and nonprofit organizations for the development and commercialization of its product candidates.

Contact Information

Website: www.bluebirdbio.com
Email: IGoldberg@bluebirdbio.com
Main Phone: +1 339 499-9300
Address: 60 Binney Street
Address 2: P.O Box 1900, Station M
State: MA
City / Town: Cambridge
Country: US
Postal Code: 02142

Issuer Information

Exchange: NGS
CEO: Nick Leschly
Employees: 1213
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)

Equities News

View More
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A